Matches in Nanopublications for { <http://bio2rdf.org/drugbank_resource:DB00907_DB04844> ?p ?o ?g. }
Showing items 1 to 4 of
4
with 100 items per page.
- drugbank_resource:DB00907_DB04844 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB00907_DB04844 label "DDI between Cocaine and Tetrabenazine - CYP2D6 Inhibitors (Strong) such as cocaine may increase the serum concentration of tetrabenazine. Specifically, concentrations of the active alpha- and beta-dihydrotetrabenazine metabolites may be increased. Patients receiving a strong inhibitor of CYP2D6 together with tetrabenazine should not exceed 50mg of tetrabenazine. Also, patients already taking tetrabenazine prior to starting a strong CYP2D6 inhibitor should have their tetrabenazine dose reduced by 50% upon initiation of the strong CYP2D6 inhibitor. [drugbank_resource:DB00907_DB04844]" assertion.
- drugbank_resource:DB00907_DB04844 identifier "drugbank_resource:DB00907_DB04844" assertion.
- drugbank_resource:DB00907_DB04844 title "DDI between Cocaine and Tetrabenazine - CYP2D6 Inhibitors (Strong) such as cocaine may increase the serum concentration of tetrabenazine. Specifically, concentrations of the active alpha- and beta-dihydrotetrabenazine metabolites may be increased. Patients receiving a strong inhibitor of CYP2D6 together with tetrabenazine should not exceed 50mg of tetrabenazine. Also, patients already taking tetrabenazine prior to starting a strong CYP2D6 inhibitor should have their tetrabenazine dose reduced by 50% upon initiation of the strong CYP2D6 inhibitor." assertion.